Influence of glucose supplementation and inoculum size on growth kinetics and antifungal susceptibility testing of Candida spp.

Journal of Clinical Microbiology

Volumn 39, Issue 2, 2001, Pages 525-532

  Cuenca Estrella, M ^a   Diaz Guerra T M ^a   Mellado, E ^a   Rodriguez Tudela J L ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; GLUCOSE; ITRACONAZOLE; KETOCONAZOLE; VORICONAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA LUSITANIAE; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; FUNGUS CULTURE; FUNGUS GROWTH; INCUBATION TIME; KINETICS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; CULTURE MEDIA; GLUCOSE; HUMANS; KINETICS; MICROBIAL SENSITIVITY TESTS; MYCOLOGY; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CLAVISPORA LUSITANIAE; FUNGI; ISSATCHENKIA ORIENTALIS;

EID: 0035123002     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.2.525-532.2001     Document Type: Article

References (21)

1. Antifungal resistance trends towards the year 2000: Implications for therapy new approaches
2. Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard
3. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents
4. Fluconazole susceptibilities of bloodstream Candida sp. isolates as determined by National Committee for Clinical Laboratory Standards method M27-A and two other methods
5. Collaborative comparison of broth macro- and microdilution antifungal tests
6. Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for is vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans
7. Antifungal agents and susceptibility tests
8. Optimizing voriconazole susceptibility testing of Candida: Effects of incubation time, endpoint rule, species of Candida, and level of fluconazole susceptibility
9. Comparison of three methods of determining MICs for filamentous fungi using different end point criteria and incubation periods
10. Influence of incubation time, inoculum size, glucose concentration on spectrophotometric endpoint determinations for amphotericin B, fluconazole, and itraconazole
11. Antifungal susceptibility testing of yeasts: Evaluation of technical variables for tests automation
12. Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to tests five antifungal agents, including the new triazole D0870
13. Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method
14. Antifungal susceptibility testing
15. Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis
16. Improved medium for fluconazole susceptibility testing of Candida albicans
17. Defining conditions for microbroth antifungal susceptibility testing: Influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria
18. Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans
19. Influence of shaking on antifungal susceptibility testing of Cryptococcus neoformans: A comparison of the NCCLS standard M27 A medium, buffered yeasts nitrogen base, and RPMI-2% glucose
20. Effects of incubation time and buffer concentration on in vitro activities of antifungal agents against Candida albicans